Revenue Recognition (Additional Information) (Details) - USD ($) $ in Thousands			1 Months Ended	3 Months Ended
	Mar. 24, 2023	Apr. 18, 2022	Feb. 25, 2022	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022
Defined Benefit Plan Disclosure [Line Items]
Common Stock, Shares, Outstanding				53,990,000		53,877,000
Due from Radionetics				$ 99		$ 135
Upfront Payment As License Revenue				600	$ 3,100
Current deferred revenues				2,121		2,240
Non - current deferred revenues				5,615		6,101
Other Assets, Noncurrent				$ 2,000		37
Common Stock
Defined Benefit Plan Disclosure [Line Items]
Issuance of common stock, net of transaction costs, shares		5,625,563
Radionetics
Defined Benefit Plan Disclosure [Line Items]
Aggregate equity interest				56.00%
Transferred at Point in Time [Member]
Defined Benefit Plan Disclosure [Line Items]
Upfront Payment As License Revenue					1,500
Transferred over Time [Member]
Defined Benefit Plan Disclosure [Line Items]
Upfront Payment As License Revenue					$ 1,600
Sanwa Kagaku Kenkyusho Co., Ltd
Defined Benefit Plan Disclosure [Line Items]
Current deferred revenues				$ 7,736		$ 8,341
Non - current deferred revenues				5,615
Sanwa Kagaku Kenkyusho Co., Ltd | Radionetics
Defined Benefit Plan Disclosure [Line Items]
Sales and Royalties milestones			$ 13,000
Non refundable, upfront payment			13,000
Additional milestone payments			$ 25,500
Cellular Longevity Inc doing business as Loyal [Member]
Defined Benefit Plan Disclosure [Line Items]
Revenue				2,100
Non refundable, upfront payment	$ 100
Cellular Longevity Inc doing business as Loyal [Member] | Convertible Preferred Stock [Member]
Defined Benefit Plan Disclosure [Line Items]
Upfront payment	$ 2,000
Other Assets, Noncurrent				$ 2,000